CLINICAL_TRIALS
trial_result
· 2015-09-03
Clinical Trial Update: A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects [Phase 1]
Summary
Phase 1 clinical trial evaluating OPC-34712 in subjects with normal hepatic function and hepatic impairment completed; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2015-09-03